
Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …

Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …

The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …

Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …

The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …

The Lancet has retracted a paper that claimed to show that people who took hydroxychloroquine to treat COVID-19 had a …

As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …

The Trump administration has selected the finalists for the COVID-19 vaccine it is seeking to make widely available by the …

The FDA has granted emergency approval for Fitbit’s ‘Fitbit Flow’ ventilator, a low cost piece of equipment to help fight …

The malaria drug hydroxychloroquine does not protect people from COVID-19, according to a new study led by researchers at the …

India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …

The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …

The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …

Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …